ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1273–1284 of 2020 project topics
ED with Clefting Gene Panel Development
Creating panels for ectodermal dysplasia-cleft lip/palate syndromes including PVRL1, PVRL4, and NECTIN3 for molecular differential diagnosis.
Genetic Basis of Ectodermal Dysplasias Click to view more details →
Hidrotic Ectodermal Dysplasia GJB6 Testing
Developing GJB6 connexin 30 variant testing for Clouston syndrome diagnosis and differentiating from other ectodermal dysplasias.
Genetic Basis of Ectodermal Dysplasias Click to view more details →
TP63 Mutation Detection SaaS Platform for ED Diagnosis
A cloud-based diagnostic platform that sequences and analyzes TP63 gene mutations associated with ectrodactyly-ectodermal dysplasia-clefting syndrome using proprietary variant calling algorithms. This platform enables clinical laboratories to offer rapid, high-accuracy ED diagnosis with scalable throughput, generating recurring subscription revenue and per-test licensing fees.
Genetic Basis of Ectodermal Dysplasias Click to view more details →
WNT10A Pathway Analysis Tool for Commercial Dental ED Solutions
An industry-grade bioinformatics tool that maps WNT10A gene variants and their functional consequences in dental ectodermal dysplasia cases for predictive phenotyping. This solution enables dental product manufacturers and orthodontic companies to develop targeted therapeutic interventions, creating new revenue streams through licensing agreements and clinical application partnerships.
Genetic Basis of Ectodermal Dysplasias Click to view more details →
KRT5 and KRT14 Multi-Gene Screening Commercial Service
A comprehensive molecular diagnostics service that simultaneously screens KRT5 and KRT14 genes in epidermolysis bullosa simplex and related ectodermal dysplasias using next-generation sequencing. This direct-to-consumer and B2B service model captures market share in the rare disease diagnostics sector while building patient registries for pharmaceutical partnerships.
Genetic Basis of Ectodermal Dysplasias Click to view more details →
PVRL1 and PVRL4 Variant Database with Phenotype Prediction Engine
A proprietary variant interpretation database paired with machine learning phenotype prediction for pemphigus vulgaris-linked ectodermal dysplasia mutations, marketed as a white-label enterprise platform. This technology generates revenue through institutional licensing, clinical decision support subscriptions, and data licensing to pharmaceutical companies developing ED therapeutics.
Genetic Basis of Ectodermal Dysplasias Click to view more details →
NEMO IKBKG Gene Test Kit and Clinical Interpretation Software
A commercially packaged genetic test kit combined with AI-powered clinical interpretation software for detecting NEMO mutations in X-linked ectodermal dysplasia with immune dysfunction. The kit-based model enables high-volume sales to diagnostic centers while the interpretation software creates recurring software licensing revenue and premium reporting tiers.
Genetic Basis of Ectodermal Dysplasias Click to view more details →
Multi-Gene ED Panel as SaaS with Patient Portal Integration
A comprehensive SaaS platform analyzing 15+ ectodermal dysplasia-associated genes with integrated patient management and secure result delivery through a consumer-facing portal. This end-to-end solution captures revenue from laboratory partnerships, patient data analytics licensing, and premium genetic counseling service add-ons.
Genetic Basis of Ectodermal Dysplasias Click to view more details →
Extended CYP Genotyping Panel Development
Developing expanded CYP genotyping panels covering CYP2D6, CYP2C19, CYP2C9, CYP3A4, and CYP3A5 for comprehensive drug metabolism phenotype prediction.
Genetics of Drug Metabolism and Transport Click to view more details →
UGT Enzyme Pharmacogenomics Studies
Characterizing UGT1A1 and UGT2B variants affecting glucuronidation of drugs and endogenous compounds for predicting irinotecan and opioid metabolism.
Genetics of Drug Metabolism and Transport Click to view more details →
Drug Transporter Genetic Variation Characterization
Studying OATP1B1, P-glycoprotein, and BCRP transporter gene variants affecting statin, methotrexate, and other drug pharmacokinetics.
Genetics of Drug Metabolism and Transport Click to view more details →
Opioid Pharmacogenomics Testing Program
Developing CYP2D6 and OPRM1 variant-based testing programs for predicting opioid metabolism and sensitivity for improving pain management safety.
Genetics of Drug Metabolism and Transport Click to view more details →